A HEMODIALYSIS PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE

被引：0
|
作者：
Hiraga, Junji [1 ]
Nishimura, Hayato [2 ]
Kurata, Hisashi [2 ]
Kagami, Yoshitoyo [1 ]
机构：
[1] Toyota Kosei Hosp, Dept Hematol, Toyota, Japan
[2] Toyota Kosei Hosp, Dept Nephrol, Toyota, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-21-3
引用
收藏
页数：1
相关论文
共 50 条
  • [31] MONITORING OF THE CYTOGENETIC ALTERATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    De Gusmao, B.
    Campeny, A.
    Perez-Persona, E.
    Oiartzabal, I.
    Ardanaz, M.
    Menchaca, M.
    Mendizabal, A.
    Wong, J.
    Pereda, A.
    de Castro, J.
    HAEMATOLOGICA, 2013, 98 : 582 - 583
  • [32] Relationship between p53 expression and prognosis of myelodysplastic syndrome treated with azacitidine
    Satoko Oka
    Kazuo Ono
    Masaharu Nohgawa
    Journal of Hematopathology, 2020, 13 : 213 - 219
  • [33] Reduction of Extramedullary Complications in Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome Treated With Azacitidine
    Shabanova, Iren
    Cada, Michaela
    Johnston, Donna L.
    Abbott, Lesleigh S.
    Leung, Elaine W.
    Schechter, Tal
    Dror, Yigal
    Klaassen, Robert J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (03) : 170 - 174
  • [34] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 745 - 746
  • [35] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [36] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [37] MYELODYSPLASTIC SYNDROME. THERAPEUTIC ROLE OF AZACITIDINE
    Eguizabal Lorea, Arteche
    Ros Fernando, Marcotegui
    Moreno Fernando, Becerril
    Arnaiz Joana, Gonzalez
    ATENCION FARMACEUTICA, 2009, 11 (03): : 151 - +
  • [38] PYODERMA GANGRENOSUM IN A PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH DECITABINE
    Serrano, Martinez Ana
    Martinez, Hellin Angela
    Berenguer, Romero Maria Dolores
    Palacios, Torres Cynthia Guadalupe
    Gomez, Catalan Irene
    Montoya, Morcillo Maria del Camen
    Sanchez, Jaen Maria
    Ibanez, Garcia Angela
    Romero, Macias Juan Ramon
    HAEMATOLOGICA, 2020, 105 : 388 - 389
  • [39] Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy
    Kaur, Jaspreet
    Tuler, Shahaf
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1775 - 1778
  • [40] Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan
    Hayashi, Makoto
    Takayasu, Hiromi
    Tada, Mami
    Yamazaki, Yohei
    Tateno, Hidetsugu
    Tazawa, Sakiko
    Wakabayashi, Aya
    Iwasaki, Takuya
    Tsuchiya, Yutaka
    Yamashita, Jun
    Takeda, Norikazu
    Tomita, Shogo
    Mori, Hiraku
    Kokubu, Fumio
    INTERNAL MEDICINE, 2012, 51 (17) : 2411 - 2415
12345